Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

www.ncbi.nlm.nih.gov/pmc/articles/PMC8085397/

580.pdf

watermark-silverchair-com.ep.fjernadgang.kb.dk/580.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAs8wggLLBgkqhkiG9w0BBwagggK8MIICuAIBADCCArEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMZSugL3ow7v3sUFoaAgEQgIICghNT26L4N26qHRlw01xQfhuiRfXE5vZTY4oYwkmrFkMJmsKz7M6f9oAXPajYlkihMuVxh9Mo1a726KyBkFupnb-yRzK4yaW8IV8xuPWzrooWiEIBcJPPSr49yTfArvy4VxHCIXdWrPsT60ZC5h-f7RGITMjQiWChUMBO4D1wuXbJZvIcroAmF5AGO6EKk1G3ZRrPtENUKRuzNs60MmzNYFnnI590TQTIzlVeKKhkgYSmqt_iG5bbKZ0e1sPwzub0ArpS7fMhgoZUQldLBDhZrvT8doui0cqOvC3FWvJDl_b3Hrt6Sb0fPAhPGWnejr84wB3lAkksH-XXqudpD1wlcJtrLBjaWu1B-owWDbsXAAczCdJ_G16-PJb58k_HyyJzm7zOgxZGm__jU_rUBtC6y9k74dY_U-sYMEfVI7QtZ24Gc0GOY5ByWDOYeid0_XENdVrpSvWZ7MZA8eMkZc4hutekM4Wg8styiwKWZQqneX71IIReQCC96ziFhUum-mIGdfOTzJg8CzGLKr9bnmtwDPCBOsM0nl1-V00hocqte60InTr2K7-0t_Jy34J5Tfx0uVqj9Hg59gS9jLQJia12kkAtqdBVkVtq11sY1bNfpyUavHNeNMMEjgIe90qYmZg-pS9koWwQTyJUb2-D3nKdQaUMY_mOv8o-mpNKENtnA_teoVSEAhCpk_MSWciMmlnpYjPCL-xnx1-pb8HQ8Opw_nLN4xjzaJ6I5OD7IpM42YZrdL-nR16uEYT5SmQki2xlvwre0akmYd9Mag6-OIV1eclsEiw7iehZuOFeDRhJmsACwgXanZilnge-5Djz4bbuKjPb54QeyFNK6ri3HfpyWr7S2A

beta.clinicaltrials.gov/study/NCT03518112?tab=results

beta.clinicaltrials.gov/study/NCT03518112?tab=table

ASCO: J&J's multiple myeloma toolkit expands with bispecifics data

www.fiercebiotech.com/biotech/asco-jjs-multiple-myeloma-toolkit-expands-bispecifics-data

Wikiwand - Clinical endpoint

www.wikiwand.com/en/Clinical_endpoint

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial - PubMed

pubmed.ncbi.nlm.nih.gov/23141816/

Endpoint

toolkit.ncats.nih.gov/glossary/endpoint/

Wikiwand - Relaxin receptor

www.wikiwand.com/en/Relaxin_receptor

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial - Nature Medicine

www.nature.com/articles/s41591-021-01436-0

White Matter Connection of Schizophrenia and Alzheimer’s Disease

academic.oup.com/schizophreniabulletin/article/47/1/197/5873334

Management of Neuropsychiatric Symptoms of Dementia - UpToDate

www.uptodate.com/contents/management-of-neuropsychiatric-symptoms-of-dementia?search=alzheimers%20agitation&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H565612757

Risk factors for recurrent injurious falls that require hospitalization for older adults with dementia: a population based study - BMC Neurology

bmcneurol.biomedcentral.com/articles/10.1186/s12883-016-0711-3

Alzheimer's Disease Fact Sheet

www.nia.nih.gov/health/alzheimers-disease-fact-sheet

Incidence and Prediction of Falls in Dementia: A Prospective Study in Older People

www.ncbi.nlm.nih.gov/pmc/articles/PMC2677107/

Management of neuropsychiatric symptoms of dementia - UpToDate

www.uptodate.com/contents/management-of-neuropsychiatric-symptoms-of-dementia?search=alzheimers%20agitation&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

Epidemiology of Alzheimer's Disease with the Projection of Falls Among the Aged Population

www.intechopen.com/chapters/48105

untitled - e012546.full.pdf

bmjopen.bmj.com/content/bmjopen/7/3/e012546.full.pdf

alzheimers-facts-and-figures.pdf

www.alz.org/media/documents/alzheimers-facts-and-figures.pdf

2022 Alzheimer's disease facts and figures

alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12638

Prevalence of Falls and Fractures in Alzheimer’s Patients Compared to General Population

www.ncbi.nlm.nih.gov/pmc/articles/PMC7906364/

Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease

jamanetwork.com/journals/jama/fullarticle/2442936

Overview — deep learning for molecules & materials

dmol.pub/index.html

Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?

www.ncbi.nlm.nih.gov/pmc/articles/PMC5070416/

Pharmacogenetics of anxiety and depression in Alzheimer's disease | Pharmacogenomics

www.futuremedicine.com/doi/10.2217/pgs-2022-0137

Extend Your Startups Runway: How Venture Debt Works

www.svb.com/startup-insights/venture-debt/what-is-venture-debt

Venture Debt: How It Works | Silicon Valley Bank

www.svb.com/startup-insights/venture-debt/how-does-venture-debt-work

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT - Scientific Reports

www.nature.com/articles/srep38695

Global Alzheimer’s Disease Market $6.3 Billion by 2029

www.ihealthcareanalyst.com/global-alzheimers-disease-market/

Exciva GmbH

www.exciva.com/bpsd

The Fall of the Market in the Fall of 2008

www.investopedia.com/articles/economics/09/subprime-market-2008.asp

What Is the Deal With Silicon Valley Bank?

www.reddit.com/r/OutOfTheLoop/comments/11n88pd/comment/jbm60a7/

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) - Full Text View - ClinicalTrials.gov

clinicaltrials.gov/ct2/show/NCT04576988

Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy | wizdom.ai - intelligence for everyone.

www.wizdom.ai/publication/10.3390/IJMS24032152/title/expression_of_cd22_in_triple_negative_breast_cancer_a_novel_prognostic_biomarker_and_potential_target_for_car_therapy

Merck’s Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy - Merck.com

www.merck.com/news/mercks-investigational-activin-signaling-inhibitor-sotatercept-improved-six-minute-walk-distance-by-40-8-meters-at-week-24-versus-placebo-in-adults-with-pulmonary-arterial-hypertension-on-bac/

Cowen-Research-Themes-2023.pdf

s33007.pcdn.co/wp-content/uploads/2022/12/Cowen-Research-Themes-2023.pdf

Bi-Specific and Tri-Specific Antibodies- The Next Big Thing in Solid Tumor Therapeutics

molmed.biomedcentral.com/articles/10.1186/s10020-018-0051-4

The Biggest Company in the World | Andreessen Horowitz

a16z.com/2022/11/11/the-biggest-company-in-the-world/

Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association

www.frontiersin.org/articles/10.3389/fmed.2020.604961/full

Wikiwand - Complement system

www.wikiwand.com/en/Complement_system

Orphanet: C3 glomerulopathy

www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=329918

Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria

www.ncbi.nlm.nih.gov/pmc/articles/PMC7892643/

complement system factor H diseases | Search | Elicit

elicit.org/search?q=complement+system+factor+H+diseases&token=01GSTNNQGCJ23A7WF393Z9AB1B&paper=cafb5ca588265b6f1fdb1786d2967618fa501702&column=title&s-pr=year

Effect Size

onbiostatistics.blogspot.com/2009/04/effect-size.html

Strengths & Weaknesses

www.16personalities.com/enfj-strengths-and-weaknesses

Megathread/Reading_material_and_elearning - Piracy

www.reddit.com/r/Piracy/wiki/megathread/reading_material_and_elearning/#wiki_.25BA_manga

Melatonin — Health Benefits, Dosage, Safety, Side-Effects, and More | Supplements - Examine

examine.com/supplements/melatonin/#dosage-information

Research Breakdown on Melatonin - Examine

examine.com/supplements/melatonin/research/

(8) Immunology - Innate Immunity (Complement System Overview) - YouTube

www.youtube.com/watch?v=2-57bqFSJ1E

Biologics vs small molecule drugs – what’s the difference?

www.admescope.com/whats-new/blog/2018/biologics-vs-small-molecule-drugs-whats-the-difference.html

Alexion-AstraZeneca-Rare-Disease-Investor-Event_06-SEPT-2022.pdf

www.astrazeneca.com/content/dam/az/Investor_Relations/events/Alexion-AstraZeneca-Rare-Disease-Investor-Event_06-SEPT-2022.pdf